| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $1.47B | -0.3% |
| R&D Expense | $1.3M | -48.0% |
| SG&A Expense | $488.7M | +8.1% |
| Operating Income | $88.8M | +45.7% |
| Pre-tax Income | $26.6M | +459.7% |
| Income Tax | $9.3M | +321.3% |
| Net Income | $17.3M | +279.9% |
| EPS (Basic) | $0.09 | +280.0% |
| EPS (Diluted) | $0.09 |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.5M | +15.5% |
| Accounts Receivable | $109.8M | +6.1% |
| Inventory | $403.7M | +5.5% |
| Current Assets | $573.2M | +4.6% |
| Total Assets | $2.33B | -0.0% |
| Current Liabilities | $253.7M | +13.7% |
| Long-term Debt | $708.8M | -5.9% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $183.3M | -23.0% |
| Investing Cash Flow | -$143.4M | -111.3% |
| Financing Cash Flow | -$39.3M | +75.8% |
| +280.0% |
| Total Liabilities |
| $1.15B |
| -2.4% |
| Stockholders' Equity | $1.18B | +2.4% |